Literature DB >> 10974478

Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis.

P F Rijken1, H J Bernsen, J P Peters, R J Hodgkiss, J A Raleigh, A J van der Kogel.   

Abstract

PURPOSE: To quantitatively study the spatial distribution of tumor hypoxia in relation to the perfused vasculature. METHODS AND MATERIALS: Using a human glioma xenograft model, nude mice were administered two different hypoxia markers (NITP or pimonidazole) and the perfusion marker Hoechst 33342. Frozen tumor sections were sequentially scanned for perfusion, hypoxia, and vasculature, respectively, to quantitate perfusion, vasculature, and hypoxia parameters in the same section.
RESULTS: All tumors showed incomplete perfusion. Both NITP and pimonidazole stained the same hypoxic tumor areas. No statistically significant differences between the two markers were observed. The density of the perfused vessels was inversely related to the hypoxic fraction. At critical distances from perfused vessels, hypoxia occurred. These data suggest that predominantly diffusion-limited hypoxia was detected, based on the spatial distribution of nearby vessels. Also, the proportion of hypoxia distributed over arbitrary zones of 50 microm around perfused vessels was calculated. The largest proportion of hypoxia was found at distances beyond 100 microm from perfused vessels.
CONCLUSION: With the multiple staining and functional microscopic imaging technique described here, the spatial relationship between perfused vessels and hypoxia was quantified in whole tumor cross-sections. The usefulness of this histologically-based method to quantitate morphological and physiological aspects of the tumor microenvironment was evaluated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974478     DOI: 10.1016/s0360-3016(00)00686-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  30 in total

Review 1.  Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.

Authors:  Y Waerzeggers; P Monfared; T Viel; A Faust; K Kopka; M Schäfers; B Tavitian; A Winkeler; A Jacobs
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 2.  Circulating glioma biomarkers.

Authors:  Johan M Kros; Dana M Mustafa; Lennard J M Dekker; Peter A E Sillevis Smitt; Theo M Luider; Ping-Pin Zheng
Journal:  Neuro Oncol       Date:  2014-09-24       Impact factor: 12.300

Review 3.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

4.  Dasatinib Inhibits DNA Repair after Radiotherapy Specifically in pSFK-Expressing Tumor Areas in Head and Neck Xenograft Tumors.

Authors:  Hanneke Stegeman; Paul N Span; Paul F J W Rijken; Simone C Cockx; Deric L Wheeler; Mari Iida; Albert J van der Kogel; Johannes H A M Kaanders; Johan Bussink
Journal:  Transl Oncol       Date:  2013-08-01       Impact factor: 4.243

5.  Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.

Authors:  Yuta Saito; Abhineet Uppal; Grace Byfield; Steven Budd; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

6.  Comparison of Helzel and OxyLite systems in the measurements of tumor partial oxygen pressure (pO2).

Authors:  Bixiu Wen; Muneyasu Urano; John L Humm; Venkatraman E Seshan; Gloria C Li; C Clifton Ling
Journal:  Radiat Res       Date:  2008-01       Impact factor: 2.841

Review 7.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

8.  Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy.

Authors:  Jochen Tuettenberg; Rainer Grobholz; Marcel Seiz; Marc A Brockmann; Frank Lohr; Frederik Wenz; Peter Vajkoczy
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-10       Impact factor: 4.553

9.  Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.

Authors:  Esther G C Troost; Peter Laverman; Mariëlle E P Philippens; Jasper Lok; Albert J van der Kogel; Wim J G Oyen; Otto C Boerman; Johannes H A M Kaanders; Johan Bussink
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-18       Impact factor: 9.236

10.  Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection.

Authors:  S Zoula; P F J W Rijken; J P W Peters; R Farion; B P J Van der Sanden; A J Van der Kogel; M Décorps; C Rémy
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.